Article Listing - Pfizer's Vfend on track for US approval?

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

SIEMENS IN ALBANIA

30 March 1992

Siemens of Germany will play an increasingly important role in the development of medicines in Albania, reports the Albanian Telegraphic...

NEW PHARMA PLANT FOR YUGOSLAVIA

23 March 1992

A new pharmaceutical plant is to be constructed in Vrsac in the Yugoslav province of Vojvodina as part of the...

CANADA/HONG KONG INVESTMENT PLAN

23 March 1992

Vancouver, Canada-based Chai-Na-Ta Ginseng Products has said that an unidentified major Canadian investment company and a Hong Kong group plan...

UPJOHN BUYSPAKISTAN COMPANY

23 March 1992

US drugmaker Upjohn has completed the acquisition of Kurram Chemical Co, a subsidiary of the Pakistan government-owned Federal Chemical &...

BOEH INGELHEIM CHF DRUG DISCONTINUED

23 March 1992

Boehringer Ingelheim has discontinued development of pimobendan, a compound previously under investigation as a treatment for heart failure. The announcement...

FDA SAYS PFIZER MUST WARN PATIENTS

23 March 1992

The US Food and Drug Administration has called on Pfizer Inc to warn patients an much higher risk of fracture...

SECOND EUROPLANT FOR UPJOHN

23 March 1992

US pharmaceuticals major Upjohn is to open a second plant in Europe with a capacity of bet-ween 7,000 and 10,000...

LEDERLE EXPANDS PATCH STRENGTH

23 March 1992

In a move to increase sales of its ProStop nicotine patch, which gained US marketing approval on January 28, US-based...

Showing 94761-94770 of 95569 articles